SOUTH SAN FRANCISCO, CA--(Marketwire - January 31, 2008) - Cytokinetics, Incorporated (NASDAQ: CYTK) reported revenues from research and development collaborations of $3.1 million for the fourth quarter of 2007. Net loss for the fourth quarter of 2007 was $13.3 million, or $0.27 per share. As of December 31, 2007, cash, cash equivalents, restricted cash and marketable securities totaled $144.9 million.
